(NEO) stock saw a modest uptick, ending the day at $14.71 which represents a slight increase of $0.93 or 6.75% from the prior close of $13.78. The stock opened at $14.95 and touched a low of $14.48 ...

Benchmark analyst maintained a Hold rating on shares of Neogenomics (NASDAQ: NEO). The analysis comes ahead of the company's investor conference presentation scheduled for the same day. The company, ...

On Monday, NeoGenomics, Inc. (NEO) stock saw a decline, ending the day at $12.63 which represents a decrease of $-2.14 or -14.49% from the prior close of $14.77. The stock opened at $14.11 and touched ...

Benchmark Co. analyst Bruce Jackson maintained a Hold rating on NeoGenomics (NEO – Research Report) today. The company’s shares closed ...

The put/call ratio of NEO is 0.21, indicating a bullish outlook ... Additionally, our exclusive stock picks are powered by ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on NeoGenomics (NEO – Research Report). The company’s shares ...

Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.

For further insights into TSE:NEO stock, check out TipRanks’ Stock Analysis page. TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In the last twelve months Neo Performance Materials insiders were buying shares, but not selling. You can see the insider transactions (by companies and individuals) over the last year depicted in the ...

NeoGenomics (NEO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. FT.